Clarus Therapeutics Holdings, Inc.
SEC CIK 1817944 · CRXT · last insider filing 2022-06-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Prygocki Mark A SR | Director | filed 2021 - 2022 |
| Cermak Elizabeth | Director | filed 2021 - 2022 |
| Hernandez Joseph | Director · Chief Executive Officer | filed 2021 - 2022 |
| Murphy Kimberly M | Director | filed 2020 - 2022 |
| Amory John Kenneth | Director | filed 2021 - 2022 |
| Dudley Robert E. | Director · Chief Executive Officer | filed 2021 - 2021 |
| Zisson Alex | Director | filed 2021 - 2021 |
| Sapirstein James | Director | filed 2020 - 2020 |
| Lerner Michael J. | Director | filed 2020 - 2020 |
| Mcburney Yvonne | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Peterson Richard D | Chief Financial Officer | filed 2021 - 2021 |
| Bourne Steven A. | Chief Administrative Officer | filed 2021 - 2021 |
| Jaeger Frank | Chief Commercial Officer | filed 2021 - 2021 |
| Garfield Jon | Chief Financial Officer | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.